Agreement with leading group purchasing organization (GPO) provides access to approximately 35 million U.S. commercial lives (20% of ~177 million ...
On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.
Fibromyalgia is the medical term used to describe the condition of widespread pain and discomfort in muscles and connective ...
A new population-based, case-control study matched adults with fibromyalgia by age and sex to control subjects without fibromyalgia in a 1:5 ratio. Compared to controls, individuals with fibromyalgia ...
Tonix Pharmaceuticals has announced the publication of its Phase 3 RESILIENT trial results for TNX-102 SL, a sublingual formulation of cyclobenzaprine for treating fibromyalgia. The data shows that ...
“This is the primary reason people with fibromyalgia search for a compassionate provider,” says Kevin V. Hackshaw, MD, a board-certified rheumatologist who specializes in fibromyalgia at UT Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results